Is Vertex Pharmaceuticals a Good Stock to Buy Right Now?

Cory Renauer, The Motley Fool
·4 min read
Is Vertex Pharmaceuticals a Good Stock to Buy Right Now?

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are miles below the impressive peaks the biotech stock reached last summer, largely due to a midstage clinical trial mishap that happened last fall. The company's successful cystic fibrosis franchise appears unstoppable now, but doubts about future drug development have weighed heavily on the stock. Could beaten-down Vertex Pharmaceuticals stock give your portfolio a lift in 2021 and beyond?